Neurolief
PrivateLast Round
Convertible Debt
Mar 26, 2026
Total Funding Raised
$22.05M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Neurolief is a medical device company that develops non-invasive, wearable brain neuromodulation systems for the at-home treatment of neurological and neuropsychiatric disorders such as migraine and major depressive disorder.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Mental Health, Health IoT
Business Model
B2B2C
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neurolief Comparables
Compare Neurolief with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sooma | 84% | |
| Flow Neuroscience | 83% | |
| Theranica | 82% |
Neurolief Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | Mar 26, 2026 | ||||
| Convertible Debt | Aug 21, 2025 | ||||
| Strategic | Dec 28, 2023 | ||||
| Series A | May 9, 2018 | ||||
| Series A | Jun 1, 2017 | ||||
Seed | Jan 1, 2015 |
Neurolief Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Champel Capital | Series A |
| Terralab Ventures | Series A, Seed |
| KT Squared | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased to 24, 80% of headcount.
- Mar 26, 2026
Raised $6M in early funding.
Recent news
Latest coverage and updates
- signs_new_clientAug 11, 2026
Neurolief signed new client Veterans Affairs on Aug 11th '26.
Neurolief Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Neurolief's valuation, stock price, and market status.
Is Neurolief a public or private company?
Neurolief is a private company.
What is the current stock price of Neurolief?
Neurolief is a private company with no public stock price. No recent secondary market data is available.
How much is Neurolief worth (valuation)?
Valuation information for Neurolief is not publicly available.
Can I buy Neurolief stock?
Neurolief shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Neurolief's last funding round?
Neurolief's most recent funding round was Early Funding on March 26, 2026.
Who are the main investors in Neurolief?
Key investors in Neurolief include Terralab Ventures.
Will Neurolief IPO soon?
No public IPO plans have been announced for Neurolief.
How can I track Neurolief secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Neurolief's secondary market activity and sign up for updates.